Market closedNon-fractional
Zoetis/ZTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Zoetis
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Ticker
ZTS
Sector
Healthcare
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Parsippany, United States
Employees
14,100
Website
www.zoetis.com
Zoetis Metrics
BasicAdvanced
$82B
Market cap
34.83
P/E ratio
$5.19
EPS
0.86
Beta
$1.56
Dividend rate
0.86%
Dividend yield
Price and volume
Market cap
$82B
Beta
0.86
Dividend rate
$1.56
Financial strength
Current ratio
3.331
Quick ratio
1.712
Long term debt to equity
134.125
Total debt to equity
134.6
Dividend payout ratio (TTM)
29.95%
Interest coverage (TTM)
13.44%
Management effectiveness
Return on assets (TTM)
13.99%
Return on equity (TTM)
50.05%
Valuation
Price to earnings (TTM)
34.826
Price to revenue (TTM)
9.516
Price to book
16.34
Price to tangible book (TTM)
82.32
Price to free cash flow (TTM)
47.493
Dividend yield (TTM)
0.86%
Growth
Revenue change (TTM)
7.91%
Earnings per share change (TTM)
17.49%
3-year revenue growth (CAGR)
7.59%
3-year earnings per share growth (CAGR)
11.85%
3-year dividend per share growth (CAGR)
22.36%
What the Analysts think about Zoetis
Analyst Ratings
Majority rating from 18 analysts.
Zoetis Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.2B
-1.04%
Net income
$599M
14.10%
Profit margin
27.35%
15.30%
Zoetis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.41
$1.36
$1.24
$1.38
-
Expected
$1.32
$1.36
$1.32
$1.34
$1.50
Surprise
7.19%
0.08%
-6.01%
3.30%
-
Zoetis News
AllArticlesVideos
Zoetis Inc Is Under Investigation By The Schall Law Firm And Investors With Losses Are Urged To Contact
Accesswire·4 hours ago
Zoetis Inc Is Under Investigation By The Schall Law Firm And Investors With Losses Are Urged To Contact
Accesswire·1 day ago
Zoetis Inc Is Under Investigation By The Schall Law Firm And Investors With Losses Are Urged To Contact
Accesswire·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
Sept
4
Zoetis
Dividend·Payment
$0.432
Per share
FAQs
What’s the current market cap for Zoetis stock?
Zoetis (ZTS) has a market cap of $82B as of July 26, 2024.
What is the P/E ratio for Zoetis stock?
The price to earnings (P/E) ratio for Zoetis (ZTS) stock is 34.83 as of July 26, 2024.
Does Zoetis stock pay dividends?
Yes, the Zoetis (ZTS) stock pays dividends to shareholders. As of July 26, 2024, the dividend rate is $1.557 and the yield is 0.86%. Zoetis has a payout ratio of 29.95% on a trailing twelve-month basis.
When is the next Zoetis dividend payment date?
The next Zoetis (ZTS) dividend payment is scheduled for September 04, 2024.
What is the beta indicator for Zoetis?
Zoetis (ZTS) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Zoetis stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.